Conditions: Skin Diseases, Infectious Skin Diseases, Bacterial
Keywords: Skin Infection Complicated Skin and Skin Structure Infection
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 192
Healthy volunteers: no

Brief summary:
The purpose of the study is to determine the oral dosage of TR-701 to be used in Phase III studies in patients with complicated skin and skin structure infections.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: TR-701 200 mg intervention 2: TR-701 300 mg intervention 3: TR-701 400 mg
Intervention descriptions: intervention 1: oral TR-701 200 mg for 5 to 7 days intervention 2: oral TR-701 300 mg for 5 to 7 days intervention 3: TR-701 400 mg for 5 to 7 days

Protocol document: